Herold Advisors, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Herold Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$27.79 - $50.61 $50,022 - $91,098	-1,800 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$39.62 - $69.97 $71,316 - $125,946	1,800 New	1,800 $82,000
Q4 2021 Jan 20, 2022	SELL	$58.09 - $82.51 $104,562 - $148,518	-1,800 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$58.38 - $84.96 $105,084 - $152,928	1,800 New	1,800 $112,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Herold Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Herold Advisors, Inc. with notifications on news.